G 2622
Pill imprint G 2622 has been identified as Terbutaline sulfate 5 mg.
Terbutaline is used in the treatment of premature labor; asthma, maintenance; asthma, acute and belongs to the drug classes adrenergic bronchodilators, tocolytic agents. There is no proven risk in humans during pregnancy.
Terbutaline 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Terbutaline sulfate Images
- Imprint:
-
G
2622 - Strength:
- 5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
hypromellose 2910 (6 mPa.s)
microcrystalline cellulose
corn starch
povidone k29/32
magnesium stearate
- Drug Class:
- Adrenergic bronchodilators
Tocolytic agents - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
- National Drug Code (NDC):
- 00115-2622
| NDC Code | Manufacturer / Repackager |
|---|---|
| 43063-0059 | PDRX Pharmaceuticals Inc (repackager) |
| 21695-0121 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Terbutaline Sulfate resources
- Terbutaline (Wolters Kluwer)
- Terbutaline Tablets (Wolters Kluwer)
- terbutaline (Cerner Multum)
- terbutaline inhalation (Cerner Multum)
- terbutaline (Micromedex) - Includes Dosage Information
- terbutaline Subcutaneous (Micromedex) - Includes Dosage Information
- Terbutaline Sulfate (AHFS DI)
- Terbutaline (FDA)
- Terbutaline Tablets (FDA)
- Terbutaline Sulfate (Wolters Kluwer)
Search Again
